Historically, anticoagulation has been the primary treatment for acute lower extremity deep venous thrombosis (DVT) with or without thrombolysis. Despite large amounts of clinical research data supporting an ‘open vein hypothesis’, which favours early thrombus removal, clinicians have hesitant to take this option due a historically high risk major bleeding and few notable studies that failed sh...

BACKGROUND The Ambulance Services have a critical role in the management of acute myocardial infarction (AMI). Paramedic delivered prehospital thrombolysis (PHT) has been proposed. To the authors' knowledge there has been no research carried out to ascertain the views of paramedics. METHODS The authors conducted a postal questionnaire study of 250 paramedics in the West Yorkshire Metropolitan...

Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, is an important cause of morbidity and mortality. The aim of this review is to summarize the findings from clinically important publications over the last year in the area of VTE. In this review, we discuss 11 randomized controlled trials published from March 2013 to April 2014. The COAG and the EU-PACT tr...

The standard treatment for acute deep vein thrombosis (DVT) targets to reduce immediate complications, however thrombolysis could reduce the long-term complications of post-thrombotic syndrome in the affected limb. This systematic review aimed to assess the effects of thrombolytic therapy and anticoagulation versus anticoagulation in people with deep vein thrombosis of the lower limb through th...

III Einstein International Symposium on Intensive Care and the XXX Mechanical Ventilation. Aug 16-18, 2023. Category: Hemodynamics/Shock/Sepsis Introduction: Pulmonary Embolism (PE) is a major cause of acute mortality long-term morbidity.() Anticoagulation systemic thrombolysis are initial treatment methods but can be associated with hemorrhagic side effects, excluding significant portion patie...